Enterprise Value

0.00

Cash

52.2M

Avg Qtr Burn

N/A

Short % of Float

0.86%

Insider Ownership

15.39%

Institutional Own.

23.26%

Qtr Updated

12/31/23


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
Vazalore (325mg and 81mg) Details
Pain reliever / fever reducer; aspirin therapy for vascular indications

Approved

Quarterly sales